Please login to the form below

Not currently logged in
Email:
Password:

Farxiga

This page shows the latest Farxiga news and features for those working in and with pharma, biotech and healthcare.

FDA advisors say no to empagliflozin in type 1 diabetes

FDA advisors say no to empagliflozin in type 1 diabetes

Meanwhile, in July the FDA also turned down AstraZeneca’s filing for its SGLT2 drug Farxiga (dapagliflozin) in type 1 diabetes, although the drug has been approved in this indication in

Latest news

More from news
Approximately 10 fully matching, plus 30 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics